Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to explore and define the correlations between genotype and phenotype in patients with CTNNB1 mutations as well as monitor and survey the natural history of the CTNNB1 syndrome.


Clinical Trial Description

CTNNB1 mutation is linked with autism and other neurodevelopmental disorders. So far, there have been 28 studies published describing 71 patients with this syndrome, which leaves much to be yet discovered. The goal of the study is to reach out to the community and include as many families of patients with CTNNB1 syndrome as possible to create a strong and reliable base of information. the investigators are specifically interested in the correlation between different genotypes and phenotypes and the natural course of the disease. The information gathered with this study will help understand CTNNB1 mutations as well as their effect on patient's overall health and wellbeing. The long-term goal is using this information to help create new treatment options, e.g. gene therapy. The participants will be guided through a detailed questionnaire about the patient's history, prenatal and delivery risk factors, current medical issues and standardized questionnaires on a variety of subjects that constitute the patient's health and daily function. The investigators wil ask the participants to provide results of genetic testing and other diagnostic measures, thus providing the medical community as well as the families of the patients a reliable overview of the syndrome. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04812119
Study type Observational
Source University Medical Centre Ljubljana
Contact
Status Completed
Phase
Start date March 1, 2021
Completion date November 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT01238250 - Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
Completed NCT05168969 - Hyperekplexia in Patients With CTNNB1 Mutation